1594. Outcomes in Patients Receiving Long-Acting Cabotegravir-Rilpivirine in a Community, Infusion Center-Based Administration Model in Columbus, Ohio

BACKGROUND: Long-acting cabotegravir and rilpivirine (CAB/RPV) offers a promising alternative to daily oral antiretroviral therapy (ART); however, system-level and individual challenges in wide scale implementation are anticipated. We describe a community, infusion center-based model (ICBM) for admi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Natalie, Taranto, Bradley, Sobhanie, Mohammad Mahdee, Lipps, Ashley, Lehman, Katherine, Koletar, Susan L, Malvestutto, Carlos, Patel, Yesha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678888/
http://dx.doi.org/10.1093/ofid/ofad500.1429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678888/
http://dx.doi.org/10.1093/ofid/ofad500.1429

Ejemplares similares